AKT1 and acute lymphoblastic leukemia: Loss or gain-of-function studies in acute lymphoblastic leukemia (ALL) cells identified SOX4 as a critical activator of cell proliferation and survival, and showed that it binds to, and transcriptionally activates, promoters of multiple components of the PI3K/AKT and MAPK signaling pathways [6,21].